Literature DB >> 431121

The relationships between pancreatic ductal obstruction and pancreatic secretion in man.

E P DiMagno, J R Malagelada, V L Go.   

Abstract

Precise relationships between pancreatic ductal obstruction and pancreatic secretory capacity have not been established. In this study, we describe the quantitative relationships between the lengths of opacified ducts obtained at retrograde pancreatography and the secretory capcity of the gland for volume, bicarbonate, lipase, and trypsin. Forty-five patients (17 with pancreatic cancer, 6 pancreatitis, 5 other malignancies, and 17 nonmalignant, nonpancreatic disease found at laparotomy) were studied with a method of duodenal intubation and perfusion with basal saline perfusion alone or with continuous intravenous infusion of secretin or of cholecystokinin-pancreozymin. Secretory outputs of volume, bicarbonate, and enzymes compared with the length of opacified ducts showed a significant (P less than 0.05) linear relationship for patients with pancreatic cancer, pancreatitis, and other cancers. The resulting data imply that obstruction of the pancreatic duct is important in decreasing secretion of the pancreas in pancreatic disease. The relationship between obstruction and pancreatic secretion demonstrates that a decrease in exocrine pancreatic secretion cannot be detected until more than 60% of the total length of the main pancreatic duct has been obstructed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 431121

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  14 in total

Review 1.  Human pancreatic exocrine response to nutrients in health and disease.

Authors:  J Keller; P Layer
Journal:  Gut       Date:  2005-07       Impact factor: 23.059

2.  Exocrine pancreatic function and chronic unexplained dyspepsia. A case-control study.

Authors:  R C Smith; N J Talley; O F Dent; M Jones; S L Waller
Journal:  Int J Pancreatol       Date:  1991-04

Review 3.  Exocrine pancreatic function tests.

Authors:  P G Lankisch
Journal:  Gut       Date:  1982-09       Impact factor: 23.059

Review 4.  Laboratory tests in the diagnosis of the chronic pancreatic diseases. Part 7. Comparison between function tests and morphological investigation in the diagnosis of pancreatic disease.

Authors:  E J Boyd; H Rinderknecht; K G Wormsley
Journal:  Int J Pancreatol       Date:  1988-07

5.  Placebo controlled trial of enteric coated pancreatin microsphere treatment in patients with unresectable cancer of the pancreatic head region.

Authors:  M J Bruno; E B Haverkort; G P Tijssen; G N Tytgat; D J van Leeuwen
Journal:  Gut       Date:  1998-01       Impact factor: 23.059

6.  Clinical and secretory differences in pancreatic cancer and chronic pancreatitis.

Authors:  R L Goodale; R M Condie; K Gajl-Peczalska; T Taylor; J O'Leary; T Dressel; J W Borner; M P Frick; D S Fryd
Journal:  Ann Surg       Date:  1981-08       Impact factor: 12.969

7.  Abnormalities in pancreatic secretory profiles of patients with cancer of the pancreas.

Authors:  H Rinderknecht; I G Renner; N H Stace
Journal:  Dig Dis Sci       Date:  1983-02       Impact factor: 3.199

8.  Feeding patients following pancreaticoduodenectomy: a UK national survey.

Authors:  Mary Phillips; Jeffrey T Lordan; Neville Menezes; Nariman D Karanjia
Journal:  Ann R Coll Surg Engl       Date:  2009-04-30       Impact factor: 1.891

9.  Pancreatic cancer and supportive care--pancreatic exocrine insufficiency negatively impacts on quality of life.

Authors:  H M Gooden; K J White
Journal:  Support Care Cancer       Date:  2013-02-10       Impact factor: 3.603

10.  Duodenal calcium outputs in health and pancreatic disease.

Authors:  P T Regan; J R Malagelada; E P DiMagno
Journal:  Gut       Date:  1980-07       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.